Supernus is a Rockville, Maryland pharmaceutical company that sells prescription medicines to patients through healthcare providers. It last closed at $29.04 on Nov 17, up 0.73% on the day. The average 12-month price target from 3 analysts is $60.33 (+107.8% from the last close), with a high of $87.00 and a low of $47.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell). In the past 30 days there were 2 dark pool prints totaling $1.9M, the largest $1.1M.
Each firm's latest rating on SUPN in the past 90 days
Average 12-month target
$60.33
▲ 107.8% upside
Based on 3 analysts who set a price target on SUPN in the past 90 days. The average target is $60.33, with a high of $87.00 and a low of $47.00, compared with the last close of $29.04.
Low $47.00Avg $60.33High $87.00
Blue marker: last close $29.04
Highest target$87.00
Average target$60.33
Lowest target$47.00
Latest rating changes
B of A SecuritiesInitiated
Nov 9Buy$47
Piper SandlerReinstated
Nov 4Buy$47
Cantor FitzgeraldTarget raised
Nov 4Buy$67 → $87
Cantor FitzgeraldMaintained
Jul 9Buy$67
Date
Firm
Action
Rating
Price target
Nov 9
B of A Securities
Initiated
Buy
$47
Nov 4
Piper Sandler
Reinstated
Buy
$47
Nov 4
Cantor Fitzgerald
Target raised
Buy
$67 → $87
Jul 9
Cantor Fitzgerald
Maintained
Buy
$67
Loading…
Whale Options Flow
90D
No whale options trades in SUPN in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SUPN is in one of them and how their past SUPN trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Supernus
Supernus is a pharmaceutical company based in Rockville, Maryland. It develops and sells prescription medicines, which it markets through a sales force that calls on healthcare providers. Patients use these products, and government and private health programs help pay for them. The company sells in the United States and in other countries, and it also conducts research and development to bring new medicines to market.